Delivery Order HHSN263201000054I-HHSN26300001

This is a definitive contract awarded by the Department of Veterans Affairs (VA) to The University of Texas MD Anderson Cancer Center (MD Anderson) for $972,225.00 to provide medical physics peer review of radiation therapy quality assurance operations. The contract has a firm fixed price structure and a period of performance through March 12, 2025. MD Anderson is a child entity of the University of Texas System, which has a history of receiving federal contracts and grants across various...

This is a delivery order issued under the National Cancer Institute's Cancer Prevention Agent Development Program 2012-2017 indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, to provide core infrastructure support for the program. The award has a ceiling value of $725,737.89 and an ultimate completion date of September 23, 2015. The contract is a cost-no-fee type...

This is a prime contract awarded by the U.S. government to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The contract is for $6,155,674.00 and is a Definitive Contract with Cost No Fee pricing. The place of performance is Texas, USA. The contract is for biomedical (applied/exploratory) services and does not have a set-aside designation. MD Anderson Cancer Center, a comprehensive cancer treatment and research center, has received this prime...

This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson) in the amount of $400,411.43. The contract was issued under the PREVENT Cancer Program (PREVENT) contract vehicle and supports the PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS project with a period of performance through...

This is a definitive contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System doing business as MD Anderson Cancer Center. The $440,456.00 Firm Fixed Price contract is for genome sequencing services, with a completion date of September 17, 2020. The contract has no set-aside designation. MD Anderson Cancer Center is a comprehensive...

This is a Delivery Order issued against the National Institutes of Health's PREVENT Cancer Program (PREVENT) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The award, valued at $4,445.48, was made to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for a "CONTRACT ORIENTATION AND KICKOFF MEETING" related to the PRECLINICAL PREVENT CANCER PROGRAM initiative. The award has an ultimate completion date of December 31, 2015 and does...

The University of Texas MD Anderson Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center located in Houston, Texas, received a $1.25 million firm fixed-price delivery order from the National Cancer Institute on June 26, 2023, to conduct preclinical research on a DNA vaccine targeting DKK1 (Dickkopf-1) for the prevention of multiple myeloma development. This delivery order falls under the PREVENT Cancer Preclinical Drug Development Program, a $149.995 billion...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Definitive Contract for $150,904.40 to the University of Texas MD Anderson Cancer Center, a component of the University of Texas System, for an "Invasive Mold Data Acquisition" project. The contract does not have a set-aside designation and was awarded on July 15, 2019, with a completion date of July 14, 2020. MD Anderson Cancer Center is a comprehensive cancer treatment...

This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to The University of Texas MD Anderson Cancer Center, a component of the University of Texas System. The $1,219,899.79 firm fixed price contract supports cancer prevention research through vaccination against induced antigens, as part of the PREVENT Preclinical Drug Development Program. The contract does not have a set-aside designation. MD Anderson Cancer...

The National Cancer Institute (NCI) awarded a $2,067,521.23 delivery order contract to the University of Texas MD Anderson Cancer Center (MD Anderson) to conduct early phase clinical research for the Cancer Prevention Agent Development Program. This contract is a child under the larger Cancer Prevention Agent Development Program 2012-2017 indefinite delivery vehicle. MD Anderson, as a comprehensive cancer research and treatment center, will provide various services in support of this cancer...